Safety and Effectiveness of Elotuzumab in Japanese Patients with Relapsed/Refractory Multiple Myeloma: A Post-marketing Surveillance Study
Conclusion This all-case post-marketing surveillance study showed that ELd had an acceptable tolerability profile and promising clinical activity in Japanese patients with RRMM.PMID:38494720 | DOI:10.2169/internalmedicine.2487-23
Source: Internal Medicine - Category: Internal Medicine Authors: Fumiya Kaneko Hiroshi Suzuka Tomoaki Yoshino Ryosuke Hinosugi Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cardiology | Cardiovascular | Cataracts | Dexamethasone | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology | Heart | Internal Medicine | Interstitial Lung Disease | Japan Health | Myeloma | Pancreas | Pancreatic Cancer | Revlimid | Study